Details
Title | Laboratory diagnostic pathways: clinical manual of screening methods and stepwise diagnosis. — 2nd updated and expanded edition. |
---|---|
Other creators | Hofmann Walter (Prof. Dr. med.,) ; Aufenanger Johannes ; Hoffmann Georg ; Schlecht Martin |
Collection | Электронные книги зарубежных издательств ; Общая коллекция |
Subjects | Diagnosis, Differential. ; HEALTH & FITNESS / Diseases / General ; MEDICAL / Clinical Medicine ; MEDICAL / Diseases ; MEDICAL / Evidence-Based Medicine ; MEDICAL / Internal Medicine ; EBSCO eBooks |
Document type | Other |
File type | |
Language | English |
Rights | Доступ по паролю из сети Интернет (чтение, печать, копирование) |
Record key | ocn959150136 |
Record create date | 9/24/2016 |
Allowed Actions
pdf/1354462.pdf | – |
Action 'Read' will be available if you login or access site from another network
Action 'Download' will be available if you login or access site from another network
|
---|---|---|
epub/1354462.epub | – |
Action 'Download' will be available if you login or access site from another network
|
Group | Anonymous |
---|---|
Network | Internet |
Network | User group | Action |
---|---|---|
ILC SPbPU Local Network | All |
|
Internet | Authorized users SPbPU |
|
Internet | Anonymous |
|
- Contents
- List of Authors
- I General Information
- 1 Introduction
- 1.1 Definitions
- 1.1.1 Legal Rulings
- 1.2 Historical Development
- 1.3 Diagnostic Strategies
- 1.3.1 Stepwise Diagnosis or Profile Diagnosis
- 1.3.2 Diagnostic Quality Criteria
- 1.3.3 Stepwise Diagnosis during Screening of Clinically Unremarkable Persons
- 1.4 Outlook
- 1.1 Definitions
- 2 Implementation
- 2.1 Organizational Requirements in the Hospital
- 2.2 Economic Impacts
- 2.3 Implementation of Information Technology
- 1 Introduction
- II Specialist Section
- 3 Practical Examples for Screening Examinations
- 3.1 Internist Admissions Screening
- 3.2 Acute Poisoning
- 3.2.1 Acute Drug Intoxication
- 3.2.1.1 Forms and Origins of Acute Drug Intoxication
- 3.2.2 Toxidromes
- 3.2.2.1 Anticholinergic Toxidrome
- 3.2.2.2 Cholinergic Toxidrome
- 3.2.2.3 Hallucinogenic Toxidrome
- 3.2.2.4 Opiate/Opioid Toxidrome
- 3.2.2.5 Sedative/Hypnotic Toxidrome
- 3.2.2.6 Sympathomimetic Toxidrome
- 3.2.3 Acute Poisoning of Unknown Origin
- 3.2.3.1 Forms and Origins of Acute Poisoning of Unknown Origin
- 3.2.3.2 Decision Tree for Acute Poisoning of Unknown Origin
- 3.2.1 Acute Drug Intoxication
- 3.3 Extravascular Fluids
- 3.3.1 Cerebrospinal Fluid Fistula Diagnostics
- 3.3.2 Peritoneal Dialysis Diagnostics
- 3.3.3 Chyle Diagnostics
- 3.3.4 Urine Leakage Diagnostics
- 3.3.5 Effusion Diagnostics
- 3.3.5.1 Ascites
- 3.3.5.2 Pleural Effusion
- 3.3.5.3 Pericardial Effusion
- 4 Practical Examples of Targeted Stepwise Diagnosis
- 4.1 Endocrinology
- 4.1.1 Thyroid Gland
- 4.1.1.1 Hyperthyroidism
- 4.1.1.2 Hypothyroidism
- 4.1.1.3 Pre- and Post-analytical Principles
- 4.1.1.4 Laboratory Analysis
- 4.1.2 Adrenal Glands
- 4.1.2.1 Cushing Syndrome
- 4.1.2.2 Clarification of Cushing Syndrome
- 4.1.2.3 Hypocortisolism
- 4.1.1 Thyroid Gland
- 4.2 Diabetes and Metabolism
- 4.2.1 Diabetes Mellitus
- 4.2.1.1 Diagnosis and Risk Assessment
- 4.2.1.2 Gestational Diabetes Mellitus (GDM)
- 4.2.1.3 Monitoring Diabetes Mellitus
- 4.2.2 Lipid and Lipoprotein Metabolism
- 4.2.2.1 Assessment of Cardiovascular Risk
- 4.2.2.2 Differential Diagnosis of Lipid Metabolism Disorders
- 4.2.3 Porphyrias
- 4.2.3.1 Neurovisceral Attacks
- 4.2.3.2 Photodermatoses
- 4.2.1 Diabetes Mellitus
- 4.3 Liver and Pancreatic Disorders
- 4.3.1 Hepatobiliary Disorders
- 4.3.1.1 Non-Alcoholic Fatty Liver Disease (NAFLD)
- 4.3.1.2 Acute Viral Hepatitis
- 4.3.1.3 Jaundice
- 4.3.2 Pancreatic Diseases
- 4.3.2.1 Acute Pancreatitis
- 4.3.2.2 Chronic Pancreatitis
- 4.3.1 Hepatobiliary Disorders
- 4.4 Kidneys and Efferent Urinary Tract
- 4.4.1 Ruling Out Disorders of the Kidneys and Efferent Urinary Tract
- 4.4.1.1 Medical History and Clinical Picture
- 4.4.1.2 Pre- and Post-analytical Principles of Laboratory Diagnost ics
- 4.4.1.3 Basic Diagnostics
- 4.4.1.4 Analysis
- 4.4.2 Stepwise Diagnostics of the Glomerular Filtration Rate
- 4.4.2.1 Stages of Chronic Renal failure
- 4.4.2.2 Analysis and Calculation of the Glomerular Filtration Rate
- 4.4.3 Stepwise Diagnostics of Proteinuria
- 4.4.3.1 Forms of Proteinuria
- 4.4.3.2 Decision Tree for Proteinuria
- 4.4.3.3 Quantification of Proteinuria
- 4.4.3.4 Further Diagnostics
- 4.4.3.5 Biomarkers and Proteomics
- 4.4.4 Stepwise Diagnostics of Hematuria
- 4.4.4.1 Decision Tree for Hematuria
- 4.4.5 Stepwise Diagnostics of Leukocyturia
- 4.4.5.1 Decision Tree for Leukocyturia
- 4.4.5.2 Further Diagnostics
- 4.4.5.3 Tubulointerstitial Kidney Disorders
- 4.4.6 Implementation of the Diagnostic Pathways in a Hospital and Laboratory Information System (HIS, LIS)
- 4.4.1 Ruling Out Disorders of the Kidneys and Efferent Urinary Tract
- 4.5 Hematology – Introduction and Overview
- 4.5.1 General Hematology
- 4.5.1.1 Erythropoiesis
- 4.5.1.2 Megakariopoiesis – Thrombopoiesis
- 4.5.1.3 Leukopoiesis – Generation of Myeloid Cell Lines
- 4.5.1.4 Lymphopoiesis
- 4.5.1.5 Hematopoiesis Disorders
- 4.5.2 Specialized Hematology – Pathologies, Disorders, Diagnosis, Differentiation
- 4.5.2.1 Anemia
- 4.5.2.2 Eosinophilia
- 4.5.2.3 Hemolysis
- 4.5.2.4 Monoclonal Gammopathy
- 4.5.2.5 Leukocytosis
- 4.5.2.6 Lymphocytosis
- 4.5.2.7 Neutropenia
- 4.5.2.8 Pancytopenia
- 4.5.2.9 Polycythemia
- 4.5.1 General Hematology
- 4.6 Coagulation disorders
- 4.6.1 Diagnostic Pathways for Coagulation disorders
- 4.6.1.1 Isolated aPTT Prolongation
- 4.6.1.2 Isolated Quick Time Reduction
- 4.6.1.3 Bleeding Diathesis
- 4.6.1.4 Acute Venous Thromboembolism
- 4.6.1.5 Heparin-induced Thrombocytopenia (Type 2 HIT)
- 4.6.1.6 Thrombophilia
- 4.6.1 Diagnostic Pathways for Coagulation disorders
- 4.7 Neurological Disorders
- 4.7.1 Neurological Laboratory Diagnostics
- 4.7.1.1 Characteristics of Neurological Laboratory Diagnostics
- 4.7.1.2 Cerebrospinal Fluid Diagnostic Parameters
- 4.7.1.3 Pre-analytics in Cerebrospinal Fluid Diagnostics
- 4.7.2 Diagnostic Pathways and Procedures
- 4.7.2.1 Clinical Spectrum and Underlying Guidelines from Clinical Professional Associations
- 4.7.2.2 Acute Meningitis
- 4.7.2.3 Opportunistic CNS Infections
- 4.7.2.4 Suspected SAH/Bloody Cerebrospinal Fluid
- 4.7.2.5 Radicular Syndromes
- 4.7.2.6 Meningeal carcinomatosis
- 4.7.2.7 Chronic Inflammatory CNS Disorders
- 4.7.2.8 Inflammatory Cerebrospinal Fluid Syndrome of Unknown Origin
- 4.7.2.9 Dementia Syndromes
- 4.7.2.10 Wilson’s disease
- 4.7.3 Authors and Working Group
- 4.7.3.1 Spokesperson for the Working Group
- 4.7.3.2 Members of the Working Group
- 4.7.3.3 Objective of the Neurology Working Group
- 4.7.1 Neurological Laboratory Diagnostics
- 4.8 Autoimmune disorders
- 4.8.1 Rheumatoid Arthritis Diagnostics
- 4.8.1.1 Diagnostic Scheme
- 4.8.1.2 Additional Reflections on Differential Diagnosis
- 4.8.2 Systemic Lupus Erythematosus
- 4.8.2.1 Laboratory Diagnostics
- 4.8.2.2 Reflections on Differential Diagnosis
- 4.8.1 Rheumatoid Arthritis Diagnostics
- 4.9 Allergy Diagnostics – Diagnostic Pathways
- 4.9.1 Food Allergy Diagnostics
- 4.9.2 Inhalation Allergy Diagnostics
- 4.9.3 Insect Venom Allergy Diagnostics
- 4.9.4 Drug Allergy Diagnostics
- 4.10 Ejaculate Analysis and Quality Assurance in Male Fertility Laboratories
- 4.10.1 Introduction
- 4.10.2 Pre-analytics and Macroscopic Physical Examination of Ejaculate
- 4.10.3 Microscopic Examination of Ejaculate
- 4.10.4 Further Biochemical Testing of Ejaculate
- 4.10.5 Quality Assurance in Ejaculate Analysis
- 4.1 Endocrinology
- 3 Practical Examples for Screening Examinations
- Index